Unknown

Dataset Information

Efficacy and predictor of anti-TNFα agents in patients with intestinal Behcet's disease.


ABSTRACT:

Background

Behçet's disease (BD) is a recurrent multisystem inflammatory disease. Anti-tumor necrosis factor (TNF) α agents have been used to treat patients with intestinal BD with severe disease activity or those who are resistant to conventional treatments; however, the long-term efficacy of anti-TNFα agents in intestinal BD remains unclear. In the present study, we investigated the clinical outcomes and predictors of discontinuation of anti-TNFα agents in patients with intestinal BD.

Methods

We reviewed the medical records of patients with intestinal BD who received first-line anti-TNFα agents between January 2009 and June 2020. The primary outcome was the percentage of patients who continued anti-TNFα therapy for 48 weeks. Secondary outcomes included the percentage of pa

SUBMITTER: Miyazaki H 

PROVIDER: S-EPMC8962253 | biostudies-literature | 2022 Mar

REPOSITORIES: biostudies-literature